-
Albertson JP, Clegg WJ, Reid HD, Arbise BS, Pryde J, Vaid A, Thompson-Brown R, Echols F, 2016: Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine-Illinois, 2015-2016[J]. MMWR Morb Mortal Wkly Rep, 65, 731-734. doi: 10.15585/mmwr.mm6529a2
-
Beleni AI, Borgmann S, 2018: Mumps in the vaccination age:global epidemiology and the situation in Germany[J]. Int J Environ Res Public Health, 15, 1618-. doi: 10.3390/ijerph15081618
-
Boukhvalova MS, Blanco JC, 2013: The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection[J]. Curr Top Microbiol Immunol, 372, 347-358.
-
Bukreyev A, Camargo E, Collins PL, 1996: Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene[J]. J Virol, 70, 6634-6641. doi: 10.1128/JVI.70.10.6634-6641.1996
-
Buynak EB, Hilleman MR, 1966: Live attenuated mumps virus vaccine[J]. 1. Vaccine development. Proc Soc Exp Biol Med, 123, 768-775. doi: 10.3181/00379727-123-31599
-
Cardemil CV, Dahl RM, James L, Wannemuehler K, Gary HE, Shah M, Marin M, Riley J, Feikin DR, Patel M, Quinlisk P, 2017: Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control[J]. N Engl J Med, 377, 947-956. doi: 10.1056/NEJMoa1703309
-
Clarke DK, Sidhu MS, Johnson JE, Udem SA, 2000: Rescue of mumps virus from cDNA[J]. J Virol, 74, 4831-4838. doi: 10.1128/JVI.74.10.4831-4838.2000
-
Cui A, Zhu Z, Hu Y, Deng X, Sun Z, Zhang Y, Mao N, Xu S, Fang X, Gao H, Si Y, Lei Y, Zheng H, He J, Wu H, Xu W, 2017: Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015[J]. PLoS ONE, 12, e0169561-. doi: 10.1371/journal.pone.0169561
-
Cui A, Zhu Z, Mao N, Si Y, Ma Y, Hu Y, Deng X, Wang L, Zeng L, Zhang Y, Xu W, 2018: Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China[J]. Vaccine, 36, 5725-5731. doi: 10.1016/j.vaccine.2018.08.028
-
Cusi MG, Correale P, Valassina M, Sabatino M, Valensin PE, Donati M, Gluck R, 2001: Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route[J]. Arch Virol, 146, 1241-1248. doi: 10.1007/s007050170088
-
Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin TY, Schneller S, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB, Pierson TC, Buller RM, Gale M Jr, Shi PY, Diamond MS, 2010: 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members[J]. Nature, 468, 452-456. doi: 10.1038/nature09489
-
Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V, 2020: Vaccines for measles, mumps, rubella and varicella in children[J]. Cochrane Database Syst Rev, 4, 004407-.
-
Elango N, Varsanyi TM, Kovamees J, Norrby E, 1988: Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus[J]. J Gen Virol, 69, 2893-2900. doi: 10.1099/0022-1317-69-11-2893
-
Elliott GD, Yeo RP, Afzal MA, Simpson EJ, Curran JA, Rima BK, 1990: Strain-variable editing during transcription of the P gene of mumps virus may lead to the generation of non-structural proteins NS1 (V) and NS2[J]. J Gen Virol, 71, 1555-1560. doi: 10.1099/0022-1317-71-7-1555
-
Fields VS, Safi H, Waters C, Dillaha J, Capelle L, Riklon S, Wheeler JG, Haselow DT, 2019: Mumps in a highly vaccinated Marshallese community in Arkansas, USA:an outbreak report[J]. Lancet Infect Dis, 19, 185-192. doi: 10.1016/S1473-3099(18)30607-8
-
Galazka AM, Robertson SE, Kraigher A, 1999: Mumps and mumps vaccine:a global review[J]. Bull World Health Organ, 77, 3-14.
-
Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D, 1995: A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA:generation of a novel copy-back nondefective interfering virus[J]. EMBO J, 14, 6087-6094. doi: 10.1002/j.1460-2075.1995.tb00299.x
-
Ge P, Tsao J, Schein S, Green TJ, Luo M, Zhou ZH, 2010: Cryo-EM model of the bullet-shaped vesicular stomatitis virus[J]. Science, 327, 689-693. doi: 10.1126/science.1181766
-
Gilman MSA, Liu C, Fung A, Behera I, Jordan P, Rigaux P, Ysebaert N, Tcherniuk S, Sourimant J, Eleouet JF, Sutto-Ortiz P, Decroly E, Roymans D, Jin Z, McLellan JS, 2019: Structure of the respiratory syncytial virus polymerase complex[J]. Cell, 179, 193-204. doi: 10.1016/j.cell.2019.08.014
-
Green MG, Huey D, Niewiesk S, 2013: The cotton rat (Sigmodon hispidus) as an animal model for respiratory tract infections with human pathogens[J]. Lab Anim (NY), 42, 170-176. doi: 10.1038/laban.188
-
Jin H, Clarke D, Zhou HZ, Cheng X, Coelingh K, Bryant M, Li S, 1998: Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV[J]. Virology, 251, 206-214. doi: 10.1006/viro.1998.9414
-
Kristensson K, Orvell C, Malm G, Norrby E, 1984: Mumps virus infection of the developing mouse brain-appearance of structural virus proteins demonstrated with monoclonal antibodies[J]. J Neuropathol Exp Neurol, 43, 131-140. doi: 10.1097/00005072-198403000-00003
-
Lawson ND, Stillman EA, Whitt MA, Rose JK, 1995: Recombinant vesicular stomatitis viruses from DNA[J]. Proc Natl Acad Sci U S A, 92, 4477-4481. doi: 10.1073/pnas.92.10.4477
-
Lewnard JA, Grad YH, 2018: Vaccine waning and mumps re-emergence in the United States[J]. Sci Transl Med, 10, 5945-. doi: 10.1126/scitranslmed.aao5945
-
Li J, Wang JT, Whelan SP, 2006: A unique strategy for mRNA cap methylation used by vesicular stomatitis virus[J]. Proc Natl Acad Sci U S A, 103, 8493-8498. doi: 10.1073/pnas.0509821103
-
Liang Y, Ma S, Liu L, Zhao H, Wang L, Jiang L, Xie Z, Dong C, Li Q, 2010: Identification and development of a promising novel mumps vaccine candidate strain[J]. Microbes Infect, 12, 1178-1187. doi: 10.1016/j.micinf.2010.08.004
-
Ma C, Liu Y, Tang J, Jia H, Qin W, Su Y, Wang H, Hao L, 2018: Assessment of mumps-containing vaccine effectiveness during an outbreak:Importance to introduce the 2-dose schedule for China[J]. Hum Vaccin Immunother, 14, 1392-1397. doi: 10.1080/21645515.2018.1428508
-
Ma R, Lu L, Zhou T, Pan J, Chen M, Pang X, 2018: Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016[J]. Vaccine, 36, 2589-2595. doi: 10.1016/j.vaccine.2018.03.074
-
Ma Y, Wei Y, Zhang X, Zhang Y, Cai H, Zhu Y, Shilo K, Oglesbee M, Krakowka S, Whelan SP, Li J, 2014: mRNA cap methylation influences pathogenesis of vesicular stomatitis virus in vivo[J]. J Virol, 88, 2913-2926. doi: 10.1128/JVI.03420-13
-
Marin M, Marlow M, Moore KL, Patel M, 2018: Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak[J]. MMWR Morb Mortal Wkly Rep, 67, 33-38. doi: 10.15585/mmwr.mm6701a7
-
May M, Rieder CA, Rowe RJ, 2018: Emergent lineages of mumps virus suggest the need for a polyvalent vaccine[J]. Int J Infect Dis, 66, 1-4. doi: 10.1016/j.ijid.2017.09.024
-
Muhlemann K, 2004: The molecular epidemiology of mumps virus[J]. Infect Genet Evol, 4, 215-219. doi: 10.1016/j.meegid.2004.02.003
-
Muthukrishnan S, Morgan M, Banerjee AK, Shatkin AJ, 1976: Influence of 5'-terminal m7G and 2'-O-methylated residues on messenger ribonucleic acid binding to ribosomes[J]. Biochemistry, 15, 5761-5768. doi: 10.1021/bi00671a012
-
Nogales A, Martinez-Sobrido L, 2016: Reverse genetics approaches for the development of influenza vaccines[J]. Int J Mol Sci, 18, 20-. doi: 10.3390/ijms18010020
-
Pang H, Zhou Y, Zhao W, Jiang Q, 2018: Seroprevalence and determinants associated with mumps antibodies after 20 Years of MMR vaccination in urban area of Shanghai[J]. Int J Environ Res Public Health, 15, 2089-. doi: 10.3390/ijerph15102089
-
Parker L, Gilliland SM, Minor P, Schepelmann S, 2013: Assessment of the ferret as an in vivo model for mumps virus infection[J]. J Gen Virol, 94, 1200-1205. doi: 10.1099/vir.0.052449-0
-
Pickar A, Xu P, Elson A, Zengel J, Sauder C, Rubin S, He B, 2017: Establishing a small animal model for evaluating protective immunity against mumps virus[J]. PLoS ONE, 12, e0174444-. doi: 10.1371/journal.pone.0174444
-
Poch O, Blumberg BM, Bougueleret L, Tordo N, 1990: Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses:theoretical assignment of functional domains[J]. J Gen Virol, 71, 1153-1162. doi: 10.1099/0022-1317-71-5-1153
-
Rubin S, Eckhaus M, Rennick LJ, Bamford CG, Duprex WP, 2015: Molecular biology, pathogenesis and pathology of mumps virus[J]. J Pathol, 235, 242-252. doi: 10.1002/path.4445
-
Rubin SA, Snoy PJ, Wright KE, Brown EG, Reeve P, Beeler JA, Carbone KM, 1999: The mumps virus neurovirulence safety test in Rhesus monkeys:a comparison of mumps virus strains[J]. J Infect Dis, 180, 521-525. doi: 10.1086/314905
-
Saika S, Kidokoro M, Kubonoya H, Ito K, Ohkawa T, Aoki A, Nagata N, Suzuki K, 2006: Development and biological properties of a new live attenuated mumps vaccine[J]. Comp Immunol Microbiol Infect Dis, 29, 89-99. doi: 10.1016/j.cimid.2006.01.004
-
Su M, Mao Y, Shi TC, Liao W, Xu XF, 2014: Evaluation of the neurovirulence of the strain s79 working seed lot of live attenuated mumps vaccines in rhesus monkeys[J]. Chinese Journal of New Drugs, 23, 1267-1272.
-
Sun J, Wei Y, Rauf A, Zhang Y, Ma Y, Zhang X, Shilo K, Yu Q, Saif YM, Lu X, Yu L, Li J, 2014: Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain[J]. J Virol, 88, 12348-12363. doi: 10.1128/JVI.01095-14
-
Tsurudome M, Yamada A, Hishiyama M, Ito Y, 1987: Replication of mumps virus in mouse:transient replication in lung and potential of systemic infection[J]. Arch Virol, 97, 167-179. doi: 10.1007/BF01314419
-
Wang Y, Liu R, Lu M, Yang Y, Zhou D, Hao X, Zhou D, Wang B, Li J, Huang YW, Zhao Z, 2018: Enhancement of safety and immunogenicity of the Chinese Hu191 measles virus vaccine by alteration of the S-adenosylmethionine (SAM) binding site in the large polymerase protein[J]. Virology, 518, 210-220. doi: 10.1016/j.virol.2018.02.022
-
Westphal DW, Eastwood A, Levy A, Davies J, Huppatz C, Gilles M, Lyttle H, Williams SA, Dowse GK, 2019: A protracted mumps outbreak in Western Australia despite high vaccine coverage:a population-based surveillance study[J]. Lancet Infect Dis, 19, 177-184. doi: 10.1016/S1473-3099(18)30498-5
-
Whelan SP, Barr JN, Wertz GW, 2004: Transcription and replication of nonsegmented negative-strand RNA viruses[J]. Curr Top Microbiol Immunol, 283, 61-119.
-
Wolinsky JS, Klassen T, Baringer JR, 1976: Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation[J]. J Infect Dis, 133, 260-267. doi: 10.1093/infdis/133.3.260
-
Wu L, Bai Z, Li Y, Rima BK, Afzal MA, 1998: Wild type mumps viruses circulating in China establish a new genotype[J]. Vaccine, 16, 281-285. doi: 10.1016/S0264-410X(97)00173-4
-
Wu L, Hu J, Li Z, Yang J, Sun X, 2018: Epidemiology of mumps in Shanghai, 1990-2015[J]. Chin J Vaccines Immun, 024, 43-47.
-
Xu P, Chen Z, Phan S, Pickar A, He B, 2014: Immunogenicity of novel mumps vaccine candidates generated by genetic modification[J]. J Virol, 88, 2600-2610. doi: 10.1128/JVI.02778-13
-
Xu P, Li Z, Sun D, Lin Y, Wu J, Rota PA, He B, 2011: Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus[J]. Virology, 417, 126-136. doi: 10.1016/j.virol.2011.05.003
-
Yang YT, Chow YH, Hsiao KN, Hu KC, Chiang JR, Wu SC, Chong P, Liu CC, 2016: Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology[J]. Antiviral Res, 132, 225-232. doi: 10.1016/j.antiviral.2016.06.014
-
Zengel J, Phan SI, Pickar A, Xu P, He B, 2017: Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China[J]. Vaccine, 35, 3988-3994. doi: 10.1016/j.vaccine.2017.05.084
-
Zhang Y, Wei Y, Zhang X, Cai H, Niewiesk S, Li J, 2014: Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase[J]. J Virol, 88, 11411-11429. doi: 10.1128/JVI.00876-14
-
Zhou D, Zhu MY, Wang YL, Hao XQ, Zhou DM, Liu RX, Zhang CD, Qu CF, Zhao ZY, 2019a: Attenuated MuV-S79 as vector stably expressing foreign gene[J]. World J Pediatr, 15, 511-515. doi: 10.1007/s12519-019-00287-7
-
Zhou D, Zhu MY, Wang YL, Hao XQ, Zhou DM, Liu RX, Zhang CD, Qu CF, Zhao ZY, 2019b: Establishment of an efficient reverse genetic system of Mumps virus S79 from cloned DNA[J]. World J Pediatr, 15, 499-505. doi: 10.1007/s12519-019-00286-8
-
Zust R, Cervantes-Barragan L, Habjan M, Maier R, Neuman BW, Ziebuhr J, Szretter KJ, Baker SC, Barchet W, Diamond MS, Siddell SG, Ludewig B, Thiel V, 2011: Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5[J]. Nat Immunol, 12, 137-143.